Product image of Byannli (Paliperidone Palmitate) supplied by GNH India

Byannli

Active Ingredient:
Paliperidone Palmitate
Origin:
EU

Byannli (Paliperidone Palmitate)

Byannli (Paliperidone Palmitate) is an injectable medication used for managing certain mental health conditions. Learn about its uses, effects, and precautions here.

Manufacturer / TM Owner

Janssen-Cilag International Nv

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Byannli (Paliperidone Palmitate) is primarily used for the treatment of schizophrenia in adults. This medication is designed to help manage symptoms associated with this condition, providing long-term relief. Byannli is administered via intramuscular injection, making it a convenient option for those who prefer or require this method of administration.

Side Effects

  • Common effects of Byannli may include drowsiness, dizziness, and weight gain. Some individuals may also experience injection site reactions. These effects can vary from person to person, and it's important to monitor how your body responds to the medication.

Precautions & Warnings

  • Byannli should be used with caution in individuals with a history of heart problems, seizures, or diabetes. It is important to discuss your medical history with your healthcare provider before starting this medication. Always follow the prescribed dosage and administration instructions to minimize potential risks.

Avoid Interactions

  • Byannli may interact with other medications, including those that affect the central nervous system. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Alcohol and certain supplements may also interact with Byannli, so it's best to consult with a healthcare professional before combining them.

Frequently Asked Questions

Byannli is used for the treatment of schizophrenia in adults, helping to manage symptoms associated with this condition.

Byannli is administered via intramuscular injection, typically by a healthcare professional.

Common side effects may include drowsiness, dizziness, weight gain, and injection site reactions.

Byannli may interact with other medications, so it's important to discuss all your current medications with your healthcare provider.

Individuals with a history of heart problems, seizures, or diabetes should use Byannli with caution and under medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Paliperidone Palmitate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT